Ensign Peak Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Ensign Peak Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Hold	3,843	–	–	﹤0.01%	1527
2026 Q1	$127K	Hold	3,843	–	–	﹤0.01%	1502
2025 Q4	$178K	Sell	3,843 -6,100	-61%	-$255K	﹤0.01%	1363
2025 Q3	$348K	Sell	9,943 -7,850	-44%	-$273K	﹤0.01%	1531
2025 Q2	$526K	Sell	17,793 -4,150	-19%	-$118K	﹤0.01%	1539
2025 Q1	$655K	Hold	21,943	–	–	﹤0.01%	1459
2024 Q4	$629K	Hold	21,943	–	–	﹤0.01%	1535
2024 Q3	$848K	Hold	21,943	–	–	﹤0.01%	1418
2024 Q2	$707K	Hold	21,943	–	–	﹤0.01%	1483
2024 Q1	$852K	Sell	21,943 -1,107	-5%	-$38.7K	﹤0.01%	1421
2023 Q4	$709K	Hold	23,050	–	–	﹤0.01%	1558
2023 Q3	$515K	Hold	23,050	–	–	﹤0.01%	1581
2023 Q2	$495K	Hold	23,050	–	–	﹤0.01%	1634
2023 Q1	$553K	Hold	23,050	–	–	﹤0.01%	1619
2022 Q4	$535K	Buy	23,050 +10,500	+84%	+$212K	﹤0.01%	1602
2022 Q3	$201K	Hold	12,550	–	–	﹤0.01%	1874
2022 Q2	$222K	Hold	12,550	–	–	﹤0.01%	1761
2022 Q1	$256K	Hold	12,550	–	–	﹤0.01%	1808
2021 Q4	$234K	Sell	12,550 -250	-2%	-$4.87K	﹤0.01%	1887
2021 Q3	$253K	Buy	12,800 +5,300	+71%	+$115K	﹤0.01%	1724
2021 Q2	$177K	Buy	7,500 +3,200	+74%	+$73.9K	﹤0.01%	1734
2021 Q1	$102K	Buy	+4,300	New	+$102K	﹤0.01%	1773

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ensign Peak Advisors's COLL Position: Q2 2026 in Review

Ensign Peak Advisors held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 3,843 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Ensign Peak Advisors first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. The position peaked at $852K in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Ensign Peak Advisors held 3,843 shares of Collegium Pharmaceutical worth $139K as of Q2 2026.
Ensign Peak Advisors left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1527 holding.
Ensign Peak Advisors first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
Ensign Peak Advisors's Collegium Pharmaceutical position peaked at $852K in Q1 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.